Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia L Darlington

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|July 28, 2005
Astrocytes as targets for neuroprotective drugsCynthia L Darlington
Current Opinion in Investigational Drugs (London, England : 2000)|July 28, 2005
NBI-5788 NeurocrineCynthia L Darlington
Current Opinion in Investigational Drugs (London, England : 2000)|November 6, 2007
The changing face of insulin receptorsCynthia L Darlington
Current Opinion in Molecular Therapeutics|December 24, 2005
Technology evaluation: NeuroVax, Immune Response CorpCynthia L Darlington
Idrugs : the Investigational Drugs Journal|October 10, 2003
Dexanabinol: a novel cannabinoid with neuroprotective propertiesCynthia L Darlington
Current Opinion in Investigational Drugs (London, England : 2000)|July 28, 2005
The potential role for statins in the treatment of multiple sclerosisCynthia L Darlington
Progress in Brain Research|October 25, 2007
Drug treatments for tinnitusCynthia L Darlington, Paul F Smith
Acta Oto-Laryngologica|February 11, 2010
A possible explanation for dizziness following SSRI discontinuationPaul F Smith, Cynthia L Darlington
Current Opinion in Investigational Drugs (London, England : 2000)|November 19, 2003
Vestibulotoxicity following aminoglycoside antibiotics and its preventionCynthia L Darlington, Paul F Smith
Current Opinion in Investigational Drugs (London, England : 2000)|July 28, 2005
Drug treatments for subjective tinnitus: serendipitous discovery versus rational drug designPaul F Smith, Cynthia L Darlington
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Opinion in Investigational Drugs (London, England : 2000)|July 28, 2005
Astrocytes as targets for neuroprotective drugsCynthia L Darlington
Current Opinion in Investigational Drugs (London, England : 2000)|July 28, 2005
NBI-5788 NeurocrineCynthia L Darlington
Current Opinion in Investigational Drugs (London, England : 2000)|November 6, 2007
The changing face of insulin receptorsCynthia L Darlington
Current Opinion in Molecular Therapeutics|December 24, 2005
Technology evaluation: NeuroVax, Immune Response CorpCynthia L Darlington
Idrugs : the Investigational Drugs Journal|October 10, 2003
Dexanabinol: a novel cannabinoid with neuroprotective propertiesCynthia L Darlington
Current Opinion in Investigational Drugs (London, England : 2000)|July 28, 2005
The potential role for statins in the treatment of multiple sclerosisCynthia L Darlington
Progress in Brain Research|October 25, 2007
Drug treatments for tinnitusCynthia L Darlington, Paul F Smith
Acta Oto-Laryngologica|February 11, 2010
A possible explanation for dizziness following SSRI discontinuationPaul F Smith, Cynthia L Darlington
Current Opinion in Investigational Drugs (London, England : 2000)|November 19, 2003
Vestibulotoxicity following aminoglycoside antibiotics and its preventionCynthia L Darlington, Paul F Smith
Current Opinion in Investigational Drugs (London, England : 2000)|July 28, 2005
Drug treatments for subjective tinnitus: serendipitous discovery versus rational drug designPaul F Smith, Cynthia L Darlington
Pageof 10